Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Daclatasvir Zeta vs Clatazev in Healthy Volunteers
NCT02756936Phase 1Completed
- Sponsor
- Genuine Research Center
- Start
- Feb 2016
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of daclatasvir in hepatitis C (HCV) (2 arms), sponsored by Genuine Research Center. Primary endpoints: Maximal measured plasma concentration, Area under the plasma concentration-time curve from time zero to time t and 1 more. Started Feb 2016; status: completed.
02
Drugs
daclatasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02756936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02756936.